Syncona celebrates investee's positive trial data on Gaucher disease
(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease. Read More
Price | 109.20p on 31-10-2024 | at 07:59:54
---|---|
Change | -0.20p -0.18% |
Buy | 107.00p |
Sell | 110.00p |
Buy / Sell SYNC Shares |
Last Trade: | - |
Day's Volume: | 0 |
Last Close: | 109.40p |
Open: | 0.00p |
ISIN: | GG00B8P59C08 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 101.00p - 136.20p |
Market Capitalisation: | £695m |
VWAP: | 0.00p |
Shares in Issue: | 636m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Lower Yield, FTSE 250, FTSE 350
Recent Trades History Syncona (SYNC) |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|